Coldstream Capital Management Inc Viking Therapeutics, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 1,292 shares of VKTX stock, worth $36,977. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,292Holding current value
$36,977% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
436Shares Held
64.7MCall Options Held
4.75MPut Options Held
3.89M-
Vanguard Group Inc Valley Forge, PA10.2MShares$291 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$172 Million0.01% of portfolio
-
State Street Corp Boston, MA4.06MShares$116 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY3.13MShares$89.5 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.59MShares$74.2 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.19B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...